I was awake when mine we're pulled, impacted. Novacaine was used to numb it. I would much rather be knocked out for it. Of course there are other instances where IR is preferred.
"I'm sure we'll get approval here on ELI. Competition is big here. But, with ADF's piling up to replace OxyContin well then I draw a conclusion OxyContin gets the boot by FDA and the market is up for grabs."
I couldn't agree more. That's the part of competition that Sixman doesn't understand. There's no way the FDA creates a monopoly out of a company that is first to market with a ADF product. Only when there are sufficient options for doctors to prescribe will they remove the non-ADF products from the market. This will greatly increase market share for those in play.
News 
Market Data 
Discover 
